8-KFiled Aug 27, 8:00 PM ET

RemSleep Holdings: Auditor Resigns; Reviewing Q2 2026 Financials

$RMSL · RemSleep Holdings Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

RemSleep Holdings: Auditor Resigns; Reviewing Q2 2026 Financials

What Happened

  • RemSleep Holdings, Inc. announced that its independent registered public accounting firm, Fruci & Associates II, PLLC, resigned effective July 17, 2026. The resignation was not due to any disagreement over accounting or audit matters, and the parties ended the relationship amicably.
  • The company is in the process of engaging a successor PCAOB-registered independent accountant and expects to announce that appointment shortly.
  • Following a change in control and a transition in executive management during Q2 2026, current management has taken responsibility for the company’s accounting records and identified issues in the books related primarily to the recognition, classification and timing of certain liabilities, indebtedness, and payments. Management plans an additional review of the quarter ended June 30, 2026, with accounting professionals and the successor auditor once engaged.

Key Details

  • Auditor resignation date: July 17, 2026 (Fruci & Associates II, PLLC).
  • Scope of review: Q2 2026 (quarter ended June 30, 2026) financial information; potential adjustments to balance sheet accounts, liabilities, expenses, payments and related disclosures.
  • Status: No final determination yet whether prior Q2 financial statements should not be relied upon and no dollar amount or materiality has been determined.
  • Next steps: Company will complete its review, engage a successor auditor, and, if necessary, file amended reports or restatements and any required SEC disclosures.

Why It Matters

  • For investors, a change in auditor plus an internal review of Q2 financials creates uncertainty about the accuracy of recent quarterly results and timing of future filings (earnings releases, 10‑Q).
  • The review could lead to adjustments or an amended financial statement, which may affect reported liabilities, expenses or other line items — though the company has not identified any specific amounts or concluded that restatement is required.
  • Monitor RemSleep’s forthcoming announcements for (1) the appointment of the successor auditor, (2) results of the Q2 review, and (3) any amended filings or disclosure about impacts to quarterly results.